Publication Name	World Journal of Gastroenterology
Manuscript ID	25252
Country	China

Received	2016-03-01 08:20
Peer-Review Started	2016-03-02 16:29
To Make the First Decision	2016-03-21 09:32
Return for Revision	2016-03-22 10:16
Revised	2016-04-03 11:30
Second Decision	2016-04-13 07:56
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-04-20 14:18
Articles in Press	2016-04-20 14:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-05-03 11:25
Publish the Manuscript Online	2016-05-17 10:45

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Editorial
Article Title	Current treatment of chronic hepatitis C in China: Dilemma and potential problems
Manuscript Source	Invited Manuscript
All Author List	Qun-Ying Han and Zheng-Wen Liu
Funding Agency and Grant Number
Corresponding Author	Zheng-Wen Liu, MD, PhD, Professor, Department of Infectious Diseases, First Affiliated Hospital of Xi’an Jiaotong University, No. 277 West Yanta Road, Xi’an 710061, Shaanxi Province, China. liuzhengwen@medmail.com.cn
Key Words	Hepatitis C virus infection; Treatment; Direct-acting antiviral agent; Generics; China
Core Tip	This article describes the current treatment situation of chronic hepatitis C virus infection in China and discusses the potential problems pertinent to the access and the use of direct-acting antiviral agents (DAAs), especially the use of generic DAAs from various sources.
Publish Date	2016-05-17 10:45
Citation	Han QY, Liu ZW. Current treatment of chronic hepatitis C in China: Dilemma and potential problems. World J Gastroenterol 2016; 22(19): 4615-4618
URL	http://www.wjgnet.com/1007-9327/full/v22/i19/4615.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i19.4615

Full Article (PDF)	WJG-22-4615.pdf
Full Article (Word)	WJG-22-4615.doc
Manuscript File	25252-Review.doc
Answering Reviewers	25252-Answering reviewers.pdf
Audio Core Tip	25252-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	25252-Conflict-of-interest statement.pdf
Copyright License Agreement	25252-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	25252-Language certificate.PDF
Peer-review Report	25252-Peer-review(s).pdf
Scientific Misconduct Check	25252-Scientific misconduct check.pdf
Scientific Editor Work List	25252-Scientific editor work list.pdf